About Biofit
Eurasanté, IDIS and EBD collaborate to launch a new international pharma-tech transfer event ‘Biofit’.
Biofit is positioned to become a leading event focused on biotechnology innovation.
“Europe’s Universities and Institutes are a tremendous source of innovation. With pharma showing a strong interest in early stage projects, Biofit has the potential to grow into a major technology exchange,” said Philip Ledger, Corporate VP of EBD Group.
See the press release»»
Interview
Key Opinion Leader interview »»
Garold Breit, Executive Director, Technology Transfer Office, University of Manitoba, Canada
Interview
Key Opinion Leader interview »»
Nicholas Dunster, PhD, Senior Business Analyst, The Wellcome Trust, UK